SE412393B - Foerfarande foer acylering av p-nitrobensylester av 7-aminodesacetoxi-cefalosporansyra - Google Patents
Foerfarande foer acylering av p-nitrobensylester av 7-aminodesacetoxi-cefalosporansyraInfo
- Publication number
- SE412393B SE412393B SE7211689A SE1168972A SE412393B SE 412393 B SE412393 B SE 412393B SE 7211689 A SE7211689 A SE 7211689A SE 1168972 A SE1168972 A SE 1168972A SE 412393 B SE412393 B SE 412393B
- Authority
- SE
- Sweden
- Prior art keywords
- formula
- group
- acylation
- cephalosporin
- hydrogen atom
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 8
- 238000005917 acylation reaction Methods 0.000 title description 16
- 230000010933 acylation Effects 0.000 title description 14
- 239000002253 acid Substances 0.000 title description 3
- 229930186147 Cephalosporin Natural products 0.000 claims description 19
- 229940124587 cephalosporin Drugs 0.000 claims description 19
- 150000001780 cephalosporins Chemical class 0.000 claims description 18
- 150000008064 anhydrides Chemical class 0.000 claims description 12
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 9
- 125000006239 protecting group Chemical group 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 5
- 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims 1
- 229960001948 caffeine Drugs 0.000 claims 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims 1
- -1 p-nitrobenzyl ester Chemical class 0.000 description 19
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- 230000000903 blocking effect Effects 0.000 description 10
- NVIAYEIXYQCDAN-CLZZGJSISA-N 7beta-aminodeacetoxycephalosporanic acid Chemical compound S1CC(C)=C(C(O)=O)N2C(=O)[C@@H](N)[C@@H]12 NVIAYEIXYQCDAN-CLZZGJSISA-N 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 230000003115 biocidal effect Effects 0.000 description 6
- ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 description 5
- 229940106164 cephalexin Drugs 0.000 description 5
- 239000000203 mixture Substances 0.000 description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 125000001240 enamine group Chemical group 0.000 description 2
- 150000002148 esters Chemical group 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- UOCLXMDMGBRAIB-UHFFFAOYSA-N 1,1,1-trichloroethane Chemical compound CC(Cl)(Cl)Cl UOCLXMDMGBRAIB-UHFFFAOYSA-N 0.000 description 1
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 1
- 241000510672 Cuminum Species 0.000 description 1
- 235000007129 Cuminum cyminum Nutrition 0.000 description 1
- ZGUNAGUHMKGQNY-SSDOTTSWSA-N D-alpha-phenylglycine Chemical compound OC(=O)[C@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-SSDOTTSWSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ZGUNAGUHMKGQNY-ZETCQYMHSA-N L-alpha-phenylglycine zwitterion Chemical compound OC(=O)[C@@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-ZETCQYMHSA-N 0.000 description 1
- WRQNANDWMGAFTP-UHFFFAOYSA-N Methylacetoacetic acid Chemical compound COC(=O)CC(C)=O WRQNANDWMGAFTP-UHFFFAOYSA-N 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- YSMHTFWPDRJCMN-UHFFFAOYSA-N butan-2-yl carbonochloridate Chemical compound CCC(C)OC(Cl)=O YSMHTFWPDRJCMN-UHFFFAOYSA-N 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 238000007327 hydrogenolysis reaction Methods 0.000 description 1
- 239000003701 inert diluent Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- XMJHPCRAQCTCFT-UHFFFAOYSA-N methyl chloroformate Chemical compound COC(Cl)=O XMJHPCRAQCTCFT-UHFFFAOYSA-N 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- IVRIRQXJSNCSPQ-UHFFFAOYSA-N propan-2-yl carbonochloridate Chemical compound CC(C)OC(Cl)=O IVRIRQXJSNCSPQ-UHFFFAOYSA-N 0.000 description 1
- FVSKHRXBFJPNKK-UHFFFAOYSA-N propionitrile Chemical compound CCC#N FVSKHRXBFJPNKK-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/02—Preparation
- C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
- C07D501/06—Acylation of 7-aminocephalosporanic acid
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB4245471A GB1399349A (en) | 1971-09-11 | 1971-09-11 | Process for acylation of dephalosporin esters |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE412393B true SE412393B (sv) | 1980-03-03 |
Family
ID=10424504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7211689A SE412393B (sv) | 1971-09-11 | 1972-09-11 | Foerfarande foer acylering av p-nitrobensylester av 7-aminodesacetoxi-cefalosporansyra |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US3769280A (en:Method) |
| JP (1) | JPS4836185A (en:Method) |
| KR (1) | KR780000290B1 (en:Method) |
| AR (1) | AR199555A1 (en:Method) |
| AT (1) | AT318145B (en:Method) |
| AU (1) | AU471613B2 (en:Method) |
| BE (1) | BE788582A (en:Method) |
| CA (1) | CA979426A (en:Method) |
| CH (1) | CH590875A5 (en:Method) |
| CS (1) | CS177828B2 (en:Method) |
| DD (1) | DD101165A5 (en:Method) |
| DE (1) | DE2242684C3 (en:Method) |
| DK (1) | DK140896B (en:Method) |
| ES (1) | ES406587A1 (en:Method) |
| FR (1) | FR2154489B1 (en:Method) |
| GB (1) | GB1399349A (en:Method) |
| HU (1) | HU164271B (en:Method) |
| IE (1) | IE36621B1 (en:Method) |
| IL (1) | IL40058A (en:Method) |
| NL (1) | NL151994B (en:Method) |
| PH (1) | PH9492A (en:Method) |
| PL (1) | PL83503B1 (en:Method) |
| RO (1) | RO60507A (en:Method) |
| SE (1) | SE412393B (en:Method) |
| SU (1) | SU603341A3 (en:Method) |
| YU (1) | YU228272A (en:Method) |
| ZA (1) | ZA725352B (en:Method) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE793448A (fr) * | 1971-12-31 | 1973-06-28 | Roussel Uclaf | Procede de preparation de nouveaux derives des cephalosporines et produits obtenus |
| US3962224A (en) * | 1972-10-10 | 1976-06-08 | Merck & Co., Inc. | Cephalosporin compounds |
| GB1472746A (en) * | 1973-07-05 | 1977-05-04 | Glaxo Lab Ltd | Cephalosporin compounds |
| JPS52117957A (en) * | 1976-03-31 | 1977-10-03 | Asahi Dow Ltd | Process for manufacture of polystyrene foam |
-
0
- BE BE788582D patent/BE788582A/xx not_active IP Right Cessation
-
1971
- 1971-09-11 GB GB4245471A patent/GB1399349A/en not_active Expired
- 1971-09-24 US US00183643A patent/US3769280A/en not_active Expired - Lifetime
-
1972
- 1972-08-02 IE IE1084/72A patent/IE36621B1/xx unknown
- 1972-08-02 CA CA148,543A patent/CA979426A/en not_active Expired
- 1972-08-04 ZA ZA725352A patent/ZA725352B/xx unknown
- 1972-08-07 IL IL40058A patent/IL40058A/xx unknown
- 1972-08-21 KR KR7201255A patent/KR780000290B1/ko not_active Expired
- 1972-08-30 PH PH13855*UA patent/PH9492A/en unknown
- 1972-08-30 DE DE2242684A patent/DE2242684C3/de not_active Expired
- 1972-09-05 SU SU721825707A patent/SU603341A3/ru active
- 1972-09-06 JP JP47089435A patent/JPS4836185A/ja active Pending
- 1972-09-07 DD DD165507A patent/DD101165A5/xx unknown
- 1972-09-08 AT AT773372A patent/AT318145B/de not_active IP Right Cessation
- 1972-09-08 NL NL727212212A patent/NL151994B/xx not_active IP Right Cessation
- 1972-09-08 AR AR243990A patent/AR199555A1/es active
- 1972-09-08 YU YU02282/72A patent/YU228272A/xx unknown
- 1972-09-08 PL PL1972157659A patent/PL83503B1/pl unknown
- 1972-09-08 CS CS6163A patent/CS177828B2/cs unknown
- 1972-09-11 ES ES406587A patent/ES406587A1/es not_active Expired
- 1972-09-11 SE SE7211689A patent/SE412393B/sv unknown
- 1972-09-11 RO RO72191A patent/RO60507A/ro unknown
- 1972-09-11 DK DK447472AA patent/DK140896B/da not_active IP Right Cessation
- 1972-09-11 CH CH1329272A patent/CH590875A5/xx not_active IP Right Cessation
- 1972-09-11 HU HULI236A patent/HU164271B/hu unknown
- 1972-09-11 FR FR7232126A patent/FR2154489B1/fr not_active Expired
- 1972-09-11 AU AU46524/72A patent/AU471613B2/en not_active Expired
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU731413B2 (en) | Crystalline amine salt of cefdinir | |
| US3694437A (en) | Process for preparing cephalosporin compounds | |
| KR920002869B1 (ko) | 7-아미노-3-치환된-메틸-3-세펨-4-카복실산 및 그의 저급 알킬실릴 유도체의 제조방법 | |
| JP2005521634A (ja) | レパグリニドの製法 | |
| EP3347362B1 (en) | Process for preparing ceftolozane from 7-aminocephalosporanic acid (7-aca) | |
| SE412393B (sv) | Foerfarande foer acylering av p-nitrobensylester av 7-aminodesacetoxi-cefalosporansyra | |
| EP0113568B1 (en) | Intermediates for the preparation of ceftazidine, and process for their preparation | |
| US3769281A (en) | Deblocking process for cephalosporin antibiotics | |
| WO1995035020A2 (en) | Glutaryl 7-aca derivatives and processes for obtaining them | |
| US3671449A (en) | Cephalosporin compositions | |
| NZ231369A (en) | Crystalline n,n'-dimethylformamide - solvate forms of a 1-carbacephalosporin derivative | |
| HU188767B (en) | Process for producing 7-/trimethylsilyloxi-carbonyl/-amino-3-cepheme-4-carboxylic acid derivatives | |
| EP0445822A1 (en) | Thiazolinoazetidinone derivative and process for preparing 2-exo-methylene-penam derivative thereform | |
| US3946002A (en) | Process for preparing cephalosporins | |
| KR0174432B1 (ko) | 신규한 결정성 세프디니르 중간체 및 그의 제조방법 | |
| KR890004562B1 (ko) | 결정성 세팔로스포린 일수화물 및 이의 제조방법 | |
| EP0348124B1 (en) | Intermediate for 1-carba(dethia)cephalosporin | |
| KR870002003B1 (ko) | 7-(d-2-포밀옥시-2-페닐아세트아미도)-3-(1-메틸-1h-테트라졸-5-일티오메틸)-3-세펨-4-카복실산 유도체의 신규 제조방법 | |
| KR0161796B1 (ko) | 티아졸릴 유도체의 제조방법 | |
| KR790001070B1 (ko) | 세팔로스포린의 제조방법 | |
| EP0115820B1 (en) | Cephalosporin derivatives and process for their preparation | |
| ARIMOTO et al. | SEMISYNTHETIC β-LACTAM ANTIBIOTICS II. SYNTHESIS AND ANTIBACTERIAL ACTIVITY OF 7β-[2-(ACYLAMINO)-2-(2-AMINOTHIAZOL-4-YL) ACETAMIDO] CEPHALOSPORINS | |
| KR790001872B1 (ko) | 세팔로스포린의 제조방법 | |
| EP0629625A1 (en) | Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof | |
| IL45101A (en) | Process for preparing cephalosporins |